During the past decade, Primary Care Associates conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Primary Care Associates" #1 collaborator was "CoLucid Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Primary Care Associates" are "Bacterial Vaginosis" (1 trials), "Migraine Disorders" (1 trials), "Osteoarthritis, Hip" (1 trials) and "Osteoarthritis, Knee" (1 trials). Many other conditions were trialed in "Primary Care Associates" in a lesser frequency.

Most popular intervention types in "Primary Care Associates" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Lasmiditan" (1 trials), "Metronidazole" (1 trials), "Tanezumab 10 mg" (1 trials), "Tanezumab 2.5 mg" (1 trials) and "Tanezumab 5 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Primary Care Associates" are 2 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Primary Care Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Primary Care Associates, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Primary Care Associates, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".